This page lists the cancer care hospitals in our directory offering Bile Duct Cancer Treatment in Chennai, India, including Apollo Athenaa Women's Cancer Centre, Apollo Proton Cancer Centre, Apollo Hospitals, Greams Road, Gleneagles Global Hospital and others. Each listing links through to the hospital's full profile page.
Ask us about bile duct cancer treatment in Chennai, India
Share a few details and our care coordination team will get back to you with next steps.
Compare 10 accredited hospitals for Cancer Care in Chennai, India
🇮🇳 Apollo Athenaa Women's Cancer Centre
🇮🇳 Apollo Proton Cancer Centre
🇮🇳 Apollo Hospitals, Greams Road
🇮🇳 Gleneagles Global Hospital
🇮🇳 Dr. Rela Institute and Medical Centre
🇮🇳 SIMS Hospital
🇮🇳 Sankara Nethralaya
🇮🇳 Apollo First Med Hospitals, Kilpauk
🇮🇳 MIOT International
🇮🇳 MGM Healthcare
How we selected these hospitals
A hospital appears on this page when Cancer Care is among its listed specialties and it is located in Chennai, India. Hospitals are not ranked by a proprietary "best" score — the order follows the listed rating (highest first), the same field shown on each hospital's profile.
How to Select the Best Hospital for Bile Duct Cancer Treatment in Chennai, India?
Choosing the right hospital for bile duct cancer treatment is one of the most important decisions in your treatment journey. A few factors are worth weighing before you decide:
International Accreditation
Look for a hospital with international accreditation such as JCI or NABH — see the accreditation badges shown for each hospital below.
Specialization
Check that the hospital's listed specialties actually include cancer care rather than only general care.
Capacity and Track Record
Bed count and year established (shown below for each hospital) are a reasonable proxy for scale and operating experience.
Transparent Costs
Ask for an itemised, all-inclusive estimate — hospital charges, room category and stay — before you travel. Our cost calculator (linked below) gives a starting estimate.
Understanding Bile Duct Cancer Treatment
Bile duct cancer (cholangiocarcinoma) is a rare but aggressive malignancy arising from the epithelial cells lining the biliary tract, requiring a highly specialized multidisciplinary approach that integrates hepatobiliary surgery, interventional oncology, and precision medicine. With curative resection rates of 25–40% in resectable cases and improving 5-year survival outcomes through advanced targeted therapies such as IDH1 inhibitors and FGFR2 inhibitors, patients worldwide are achieving better results at internationally accredited centers. GAF Healthcare connects international patients with leading JCI- and NABH-accredited oncology hospitals in India and JCI- and DHA-accredited centers in the UAE, offering expert-level biliary oncology care at a fraction of Western costs, with comprehensive end-to-end medical tourism coordination.
Clinical Overview
Cholangiocarcinoma (bile duct cancer) originates from cholangiocytes — the epithelial cells lining the intrahepatic, perihilar (Klatskin tumor), or distal extrahepatic bile ducts. It is classified anatomically as intrahepatic (iCCA), perihilar (pCCA), or distal cholangiocarcinoma (dCCA), each with distinct surgical approaches, staging systems, and molecular profiles. The Bismuth-Corlette classification remains the cornerstone for stratifying perihilar tumors (Types I–IV), directly determining resectability and the extent of hepatic resection required. Physiologically, tumor growth causes progressive biliary obstruction, leading to cholestasis, jaundice, pruritis, malabsorption of fat-soluble vitamins, coagulopathy due to impaired vitamin K absorption, and, in advanced cases, biliary sepsis and liver failure. Elevated serum bilirubin, alkaline phosphatase, CA 19-9, and CEA are common biochemical hallmarks, though CA 19-9 lacks specificity and must be interpreted alongside cross-sectional imaging.
Full details →Who is a Candidate?
- ELIGIBLE FOR SURGICAL RESECTION (Curative Intent):
- Patients with anatomically resectable intrahepatic, perihilar, or distal bile duct tumors confirmed on MRCP and CECT
- Adequate future liver remnant (FLR): minimum 25–30% in normal liver, 40% in cirrhotic or post-chemotherapy liver (assessed by volumetric CT)
- No radiological evidence of distant metastases on PET-CT
- ECOG Performance Status 0–1
- +30 more
Treatment Options & Approaches
SURGICAL APPROACHES (Curative Intent):
1. Extended Hepatectomy with Bile Duct Excision (Perihilar / Intrahepatic CCA):
The most complex hepatobiliary procedure, involving right or left hepatectomy (often extended to segments I, IV, V, VIII), complete extrahepatic bile duct excision, regional lymphadenectomy, and Roux-en-Y hepaticojejunostomy reconstruction. Vascular resection and reconstruction of the portal vein or hepatic artery may be required in select Bismuth-Corlette Type III/IV tumors. The caudate lobe (segment I) is routinely resected for perihilar CCA given its dual biliary drainage. Intraoperative frozen section analysis of bile duct margins is mandatory to confirm R0 status.
2. Pancreaticoduodenectomy / Whipple Procedure (Distal CCA):
Full details →Recovery
PRE-OPERATIVE / PRE-TREATMENT PHASE (Weeks 1–4 before intervention):
Step 1 — Remote Case Evaluation (Before Travel):
Patient submits existing imaging (CT, MRI, MRCP, PET-CT), histopathology reports, blood work, and operative records (if any) to GAF Healthcare. Assigned hepatobiliary oncology multidisciplinary team (MDT) reviews the case. A detailed second-opinion report, treatment plan, and itemized cost estimate are provided within 72 hours.
Full details →Risks to be aware of
Bile duct cancer treatment carries a spectrum of procedure-specific and oncology-related risks that must be contextualized honestly. For major hepatectomy and bile duct excision, the most serious risks include post-hepatectomy liver failure (PHLF) — occurring in up to 8–10% of extended resections — which carries significant mortality if ISGLS Grade C is reached; bile leak (Grade B/C in 5–15% of cases, requiring percutaneous drainage or re-exploration); post-operative biliary stricture at the hepaticojejunostomy anastomosis (long-term risk of 5–10%); intra-abdominal hemorrhage; and septic cholangitis. Pancreaticoduodenectomy for distal CCA carries the additional risks of delayed gastric emptying (DGE, 15–25%), post-operative pancreatic fistula (POPF, 10–20%), and marginal ulceration. Perioperative mortality at high-volume centers is approximately 2–5% for major hepatic resections.
Full details →Why GAF Healthcare
GAF Healthcare provides comprehensive non-medical coordination services that begin the moment a patient initiates contact and continue through long-term post-treatment follow-up, regardless of whether the destination is India or the UAE.
Common questions about Bile Duct Cancer Treatment
What is the cost of Bile Duct Cancer Treatment in India vs the UAE?
How long do I need to stay in the country before I am fit to fly home after Bile Duct Cancer Treatment?
What is the success rate of Bile Duct Cancer Treatment?
Related pages
How GAF Healthcare Assists in Choosing the Best Hospital for Bile Duct Cancer Treatment in Chennai, India
Discover the Top Hospitals for Bile Duct Cancer Treatment in Chennai, India
This page lists 10 accredited cancer care hospitals in Chennai, India, so you can compare accreditation, specialties and bed capacity in one place.
Support When You Need It Most
Share your medical reports with us on WhatsApp or email. Our medical team reviews them and comes back with a recommended hospital and treatment plan for your case.
Transparent, All-Inclusive Costs
We provide a single, itemised quote covering hospital charges and stay — no hidden fees, and there's no charge for requesting an estimate. Use our cost calculator alongside this page for a first estimate.
Visa, Travel and Stay Coordination
Once you choose a hospital, we help arrange the medical visa invitation letter, hotel or serviced-apartment booking nearby, airport pickup and transport to your appointments.
Curious what treatment might cost for your case? Use our cost calculator for a personalized estimate.
Frequently asked questions about bile duct cancer treatment in Chennai, India
How many cancer care hospitals are listed in Chennai, India?
How do you choose which hospitals to list?
How much does treatment cost in India?
Are there cancer care hospitals for this in other India cities?
Next Step
Share your medical reports with us and our team will recommend a hospital and treatment plan for bile duct cancer treatment in Chennai, India.
Contact us to report an inaccuracy on this page.

